4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)benzonitrile, 95+%, 1g

1,3,5-Tris(pyridin-4-ylethynyl)benzene, 97%, 10g

Rotilabo® open containers, blue, L 332 x W 207 x H 155 mm 1 Piece

Long working distance plan phase Fluarex contrast 20x/0.45 infinity corrected IOS objective, corrected for 1 mm petri dish thickness

2-[(TERT-BUTOXY)CARBONYL]-2-AZABICYCLO[2.2.1]HEPTANE-5-CARBOXYLIC ACID, 95.0%, 1g

1H-pyrazolo[3,4-b]pyrazine-3-carboxylic acid, 95.0%, 250mg

3-(bromomethyl)-1,1-dimethylcyclobutane, 95.0%, 100mg

4,5-Dimethoxy-2-iodobenzoic acid, 98.0%, 100g

4-Decylcyclohexanone, 95%, 5g

6,7-Difluoro-3,4-dihydronaphthalen-1(2H)-one, 95.0%, 250mg

5-(2-Bromoacetyl)-2-hydroxybenzaldehyde, 95.0%, 5g

1-BROMO-2-METHYL-2-PROPANOL, 95.0%, 1g

anti-Synaptopodin/SYNPO mouse monoclonal, G1D4, 1 ml